46,XX DSD

The masculinised female

Richard J. Auchus, Alice Y Chang

Research output: Contribution to journalReview article

17 Citations (Scopus)

Abstract

The 46,XX disorders of sex development (DSDs) cause virilisation or masculinisation of the female foetus. The final common pathway of all 46,XX DSDs is excess dihydrotestosterone (DHT) or potent foreign androgen in the genital tissue during the critical period of sexual differentiation. Whereas the foetal testis is source of androgen in the male, it is the foetal adrenal that produces the DHT precursors in the female. By understanding the principles of human steroid biosynthesis, the pathogenesis of each disorder may be logically deduced, and treatment strategies are rationally constructed. In practice, however, therapies for many of these diseases are fraught with complications and caveats, and current approaches leave much room for improvement. This review discusses these diseases, their pathogenesis and approaches to therapy. We emphasise areas where improved treatments are sorely needed.

Original languageEnglish (US)
Pages (from-to)219-242
Number of pages24
JournalBest Practice and Research: Clinical Endocrinology and Metabolism
Volume24
Issue number2
DOIs
StatePublished - Apr 2010
Externally publishedYes

Fingerprint

XX Disorders of Sex Development 46
Dihydrotestosterone
Androgens
Virilism
Sex Differentiation
Testis
Fetus
Steroids
Therapeutics

Keywords

  • 46,XX DSD
  • adrenal gland
  • androgen
  • congenital adrenal hyperplasia
  • steroidogenesis
  • virilisation

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

46,XX DSD : The masculinised female. / Auchus, Richard J.; Chang, Alice Y.

In: Best Practice and Research: Clinical Endocrinology and Metabolism, Vol. 24, No. 2, 04.2010, p. 219-242.

Research output: Contribution to journalReview article

@article{4e325ef6435441d19e7b93e994a61cef,
title = "46,XX DSD: The masculinised female",
abstract = "The 46,XX disorders of sex development (DSDs) cause virilisation or masculinisation of the female foetus. The final common pathway of all 46,XX DSDs is excess dihydrotestosterone (DHT) or potent foreign androgen in the genital tissue during the critical period of sexual differentiation. Whereas the foetal testis is source of androgen in the male, it is the foetal adrenal that produces the DHT precursors in the female. By understanding the principles of human steroid biosynthesis, the pathogenesis of each disorder may be logically deduced, and treatment strategies are rationally constructed. In practice, however, therapies for many of these diseases are fraught with complications and caveats, and current approaches leave much room for improvement. This review discusses these diseases, their pathogenesis and approaches to therapy. We emphasise areas where improved treatments are sorely needed.",
keywords = "46,XX DSD, adrenal gland, androgen, congenital adrenal hyperplasia, steroidogenesis, virilisation",
author = "Auchus, {Richard J.} and Chang, {Alice Y}",
year = "2010",
month = "4",
doi = "10.1016/j.beem.2009.11.001",
language = "English (US)",
volume = "24",
pages = "219--242",
journal = "Best Practice and Research in Clinical Endocrinology and Metabolism",
issn = "1521-690X",
publisher = "Bailliere Tindall Ltd",
number = "2",

}

TY - JOUR

T1 - 46,XX DSD

T2 - The masculinised female

AU - Auchus, Richard J.

AU - Chang, Alice Y

PY - 2010/4

Y1 - 2010/4

N2 - The 46,XX disorders of sex development (DSDs) cause virilisation or masculinisation of the female foetus. The final common pathway of all 46,XX DSDs is excess dihydrotestosterone (DHT) or potent foreign androgen in the genital tissue during the critical period of sexual differentiation. Whereas the foetal testis is source of androgen in the male, it is the foetal adrenal that produces the DHT precursors in the female. By understanding the principles of human steroid biosynthesis, the pathogenesis of each disorder may be logically deduced, and treatment strategies are rationally constructed. In practice, however, therapies for many of these diseases are fraught with complications and caveats, and current approaches leave much room for improvement. This review discusses these diseases, their pathogenesis and approaches to therapy. We emphasise areas where improved treatments are sorely needed.

AB - The 46,XX disorders of sex development (DSDs) cause virilisation or masculinisation of the female foetus. The final common pathway of all 46,XX DSDs is excess dihydrotestosterone (DHT) or potent foreign androgen in the genital tissue during the critical period of sexual differentiation. Whereas the foetal testis is source of androgen in the male, it is the foetal adrenal that produces the DHT precursors in the female. By understanding the principles of human steroid biosynthesis, the pathogenesis of each disorder may be logically deduced, and treatment strategies are rationally constructed. In practice, however, therapies for many of these diseases are fraught with complications and caveats, and current approaches leave much room for improvement. This review discusses these diseases, their pathogenesis and approaches to therapy. We emphasise areas where improved treatments are sorely needed.

KW - 46,XX DSD

KW - adrenal gland

KW - androgen

KW - congenital adrenal hyperplasia

KW - steroidogenesis

KW - virilisation

UR - http://www.scopus.com/inward/record.url?scp=77956641069&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956641069&partnerID=8YFLogxK

U2 - 10.1016/j.beem.2009.11.001

DO - 10.1016/j.beem.2009.11.001

M3 - Review article

VL - 24

SP - 219

EP - 242

JO - Best Practice and Research in Clinical Endocrinology and Metabolism

JF - Best Practice and Research in Clinical Endocrinology and Metabolism

SN - 1521-690X

IS - 2

ER -